{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-25-000050","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.621545+00:00","generated_at":"2026-05-17T00:41:40.946824+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sotera Health Q3 net revenues +9.1% to $311M; adj EBITDA +12.2%; raises 2025 guidance","bullets":["Q3 net revenues rose 9.1% to $311M; net income $48M ($0.17 diluted EPS) vs $17M ($0.06) a year ago.","Adjusted EBITDA up 12.2% to $164M; Adjusted EPS $0.26 (+$0.09 YoY); constant-currency rev growth 8.0%.","Nine-month 2025 net revenues $860M (+6.2%); net income $43M includes $34M pending EO settlement charge.","2025 guidance: reaffirms constant-currency revenue growth 4.5%-6.0%; raises adj EBITDA growth to 6.75%-7.75%.","Sterigenics volumes strong; Nordion double-digit growth; Nelson Labs margin expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-25-000050","json":"https://secwatch.observer/filing/0001822479-25-000050.json","markdown":"https://secwatch.observer/filing/0001822479-25-000050.md","text":"https://secwatch.observer/filing/0001822479-25-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247925000050/0001822479-25-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247925000050/shc-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:41:40.946824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}